Paysign, Inc. (NASDAQ:PAYS) CEO Sells $81,750.00 in Stock

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 25,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $3.27, for a total value of $81,750.00. Following the completion of the sale, the chief executive officer now directly owns 9,236,886 shares of the company’s stock, valued at $30,204,617.22. This represents a 0.27 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Mark Newcomer also recently made the following trade(s):

• On Monday, November 18th, Mark Newcomer sold 40,000 shares of Paysign stock. The stock was sold at an average price of $3.24, for a total value of $129,600.00.
• On Wednesday, October 23rd, Mark Newcomer sold 36,000 shares of Paysign stock. The stock was sold at an average price of $3.66, for a total transaction of $131,760.00.
• On Monday, October 21st, Mark Newcomer sold 22,000 shares of Paysign stock. The shares were sold at an average price of $3.75, for a total transaction of $82,500.00.
• On Monday, September 23rd, Mark Newcomer sold 50,000 shares of Paysign stock. The stock was sold at an average price of $4.25, for a total value of $212,500.00.
• On Thursday, September 19th, Mark Newcomer sold 1,500 shares of Paysign stock. The shares were sold at an average price of $4.50, for a total value of $6,750.00.
• On Friday, September 13th, Mark Newcomer sold 1,500 shares of Paysign stock. The stock was sold at an average price of $4.50, for a total value of $6,750.00.

Paysign Trading Up 0.6 %

Shares of PAYS opened at $3.46 on Friday. Paysign, Inc. has a 1-year low of $2.22 and a 1-year high of $5.59. The stock has a market capitalization of $185.28 million, a P/E ratio of 23.07 and a beta of 0.95. The business’s 50-day moving average price is $3.81 and its 200 day moving average price is $4.28.

Paysign (NASDAQ:PAYS) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. Paysign had a return on equity of 30.64% and a net margin of 14.28%. The business had revenue of $15.26 million for the quarter, compared to the consensus estimate of $14.96 million. During the same quarter in the previous year, the company posted $0.02 earnings per share. On average, research analysts predict that Paysign, Inc. will post 0.21 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Barclays PLC raised its position in shares of Paysign by 327.4% during the third quarter. Barclays PLC now owns 47,090 shares of the company’s stock valued at $173,000 after buying an additional 36,071 shares during the last quarter. BNP Paribas Financial Markets boosted its position in Paysign by 257.0% in the third quarter. BNP Paribas Financial Markets now owns 44,793 shares of the company’s stock valued at $164,000 after buying an additional 32,245 shares in the last quarter. Bard Associates Inc. acquired a new position in Paysign in the third quarter valued at about $103,000. Royce & Associates LP acquired a new stake in shares of Paysign during the third quarter worth approximately $814,000. Finally, GSA Capital Partners LLP boosted its holdings in shares of Paysign by 31.2% in the 3rd quarter. GSA Capital Partners LLP now owns 117,028 shares of the company’s stock worth $429,000 after acquiring an additional 27,829 shares in the last quarter. Institutional investors own 25.89% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Barrington Research reissued an “outperform” rating and set a $7.00 price target on shares of Paysign in a research report on Monday, November 4th.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.